Fungal Epidemic, Sick Babies: Worst of Covid Plays Out in India
- Deadly fungal infection, once deemed rare, spurs drug shortage
- Doctors predict surge in inflammatory condition in children
This article is for subscribers only.
Rare, life-threatening Covid-19 complications appear to be escalating in India, creating a fresh wave of critical medical challenges in a country that has already seen short supplies of oxygen and other basic needs.
Pharmacists are warning of a shortage of a crucial drug to treat an invasive fungal infection preying on patients with weakened immune systems and diabetes. An uptick in cases across India of a dangerous inflammatory syndrome in children -- also seen in the U.S. and Europe at the height of their outbreaks -- is a harbinger of a potentially deadly spate of the pediatric illness in the coming weeks.